Main > A2. TRADEMARK. INDEX. M-Mm > Mircera

Product CH. R

GENERIC NAME This data is not available for free
STRUCTURE This data is not available for free
INDICATION'S Nephrology>CKD>Anemia>Treat.
OBSERVATION'S - Long Acting (1/4 weeks)
STATUS - EU: Approved
- USA: Approved.
- USA Patent Expiration: 06.27.2020
UPDATE 11.15.07
COMPANY This data is not available for free
PATENT NUMBER This data is not available for free

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back